Overview

fluvastatin


'fluvastatin' can also refer to...

fluvastatin n.

fluvastatin n.

fluvastatin n.

fluvastatin n.

Immunosuppression in Human Peripheral Blood T Lymphocytes by Fluvastatin

Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy

Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus

Acute cholestasis during long-term treatment with fluvastatin in a nephrotic patient.

Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

The Phototoxicity of Fluvastatin, an HMG-CoA Reductase Inhibitor, Is Mediated by the formation of a Benzocarbazole-Like Photoproduct

The Safety Evaluation of Fluvastatin, an HMG-CoA Reductase Inhibitor, in Beagle Dogs and Rhesus Monkeys

Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty Final results of the fluvastatin angiographic restenosis (FLARE) trial

Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study

O59. The Cellular Effects of Anti-Factor Xa Antibodies Isolated from Patients with Antiphospholipid Syndrome are Inhibited by Factor Xa Inhibitors, Hydroxychloroquine and Fluvastatin

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

(floo-vas-tă-tin)

a drug used to reduce abnormally high levels of cholesterol and other lipids in the blood (see statin). It is taken by mouth. Trade name: Lescol.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.